Country | ASIR 0-19 year-old | Ratio Child:adult | HDI | sEBV | tEBV |
---|---|---|---|---|---|
Sulaimani | 6.2 (4.7–7.7) | 1 : 0.19 | 0.674 | 0.92 C | 0.83 |
Egypt | 5.2 (4.2–6.2) | 1 : 0.05 | 0.707 | Na | 0.73 |
Algeria | 1.0 (0.6–1.4) | Na | 0.748 | 0.83 C | 0.88 |
Morocco | 5.0 (3.7–6.3) | Na | 0.686 | Na | Na |
Jordan | 3.7 (3.1–4.3) | 1 : 0.13 | 0.729 | 0.98 C | Na |
Israel all races | 5.0 (4.3–5.7) | Na | 0.919 | 0.87 AYD | 0.34 |
Saudi Arabia | 2.8 (2.3–3.3) | Na | 0.854 | 0.98 C | Na |
Turkey | 3.5 (3.0–4.0) | Na | 0.820 | 0.82 C | 0.93 |
S. Africa all races | 1.7 (1.5–1.9) | 1 : 2.78 | 0.709 | 0.95 EBV 0.78 HIV+ | Na |
Uganda | 21.6 (19.4–23.8) | 1 : 0.21 | 0.544 | 0.96 EC | >0.95 |
Cameroon | 40.0 (32.9–47.1) | 1 : 0.41 | 0.563 | 0.97 EC | >0.95 |
Canada | 2.5 (2.3–2.7) | 1 : 2.78 | 0.929 | 0.95 AYD | Na |
US all races | 2.4 (2.3–2.5) | 1 : 3.85 | 0.926 | 0.83 AYD | 0.30 |
UK | 2.3 (2.1–2.5) | 1 : 4.78 | 0.932 | 0.85 AYD | 0.10 |
Germany-West | 2.8 (2.4–3.2) | Na | 0.947 | 0.95 AYD | Na |
France | 4.3 (3.7–4.9) | Na | 0.901 | 0.82 AYD | Na |
Italy | 4.0 (3.5–4.5) | 1 : 0.20 | 0.892 | 0.65 AYD | 0.62 |
Spain | 4.8 (4.2–5.5) | Na | 0.904 | 0.99 AYD | Na |
Japan | 1.4 (1.1–1.7) | 1 : 2.94 | 0.919 | 0.59 AYD | 0.29 |
Korea | 2.1 (1.9–2.3) | Ped<Adult | 0.916 | 0.87 AYD | 0.00 |
China | 0.4 (0.3–0.5) | 1 : 0.55 | 0.761 | 0.80 EC | 0.32 |
Thailand | 0.8 (0.6–1.0) | Ped>Adult | 0.777 | 0.95 EC | Na |
India | 0.5 (0.4–0.6) | Ped>Adult | 0.645 | 0.90 EC | Na |